V011-9772 Screening compound: N-[4-(4-ethylpiperazin-1-yl)-3-[(1,2,3,4-tetrahydronaphthalen-1-yl)sulfamoyl]phenyl]-3-methoxybenzamide

V011-9772 Screening compound: N-[4-(4-ethylpiperazin-1-yl)-3-[(1,2,3,4-tetrahydronaphthalen-1-yl)sulfamoyl]phenyl]-3-methoxybenzamide
V011-9772 Screening compound: N-[4-(4-ethylpiperazin-1-yl)-3-[(1,2,3,4-tetrahydronaphthalen-1-yl)sulfamoyl]phenyl]-3-methoxybenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V011-9772
N-[4-(4-ethylpiperazin-1-yl)-3-[(1,2,3,4-tetrahydronaphthalen-1-yl)sulfamoyl]phenyl]-3-methoxybenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V011-9772

Molecular Formula

C30H36N4O4S (C30 H36 N4 O4 S)

Compound Name

N-[4-(4-ethylpiperazin-1-yl)-3-[(1,2,3,4-tetrahydronaphthalen-1-yl)sulfamoyl]phenyl]-3-methoxybenzamide

IUPAC name

N-[4-(4-ethylpiperazin-1-yl)-3-[(1234-tetrahydronaphthalen-1-yl)sulfamoyl]phenyl]-3-methoxybenzamide

SMILES

CCN(CC1)CCN1c(ccc(NC(c1cc(OC)ccc1)=O)c1)c1S(NC(CCC1)c2c1cccc2)(=O)=O

InChI

InChI=1S/C30H36N4O4S/c1-3-33-16-18-34(19-17-33)28-15-14-24(31-30(35)23-10-6-11-25(20-23)38-2)21-29(28)39(36,37)32-27-13-7-9-22-8-4-5-12-26(22)27/h4-6,8,10-12,14-15,20-21,27,32H,3,7,9,13,16-19H2,1-2H3,(H,31,35)/t27-/m0/s1

InChI Key

XVNQOSQWRPWYFB-MHZLTWQESA-N

MDL Number (MFCD)

MFCD19972536

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

548.71

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.140

Distribution Coefficient, logD

4.679

Water Solubility, LogSw

-4.96

Polar Surface Area

79.377

Acid Dissociation Constant (pKa)

9.73

Base Dissociation Constant (pKb)

7.68

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

36.70

V011-9772 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V011-9772 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V011-9772?
Check Price and Availability of V011-9772, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V011-9772 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V011-9772
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V011-9772
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V011-9772 available by request